Human Leucocyte Antigen Sensitisation and Its Impact on Transfusion Practice

Area of Science:

• Transfusion Medicine
• Immunology
• Hematology

Background:

• Human leucocyte antigen (HLA) sensitization can cause severe transfusion complications.
• Donor HLA antibodies can trigger transfusion-associated lung injury (TRALI).
• Patient HLA antibodies lead to platelet destruction and refractoriness.

Purpose of the Study:

• To review the mechanisms of HLA sensitization.
• To discuss methods for detecting and identifying HLA antibodies.
• To explore strategies for providing HLA-compatible blood products to sensitized patients.

Main Methods:

• Review of existing literature on HLA sensitization and transfusion reactions.
• Discussion of various HLA antibody detection techniques (e.g., cytotoxicity assays, bead-based assays).
• Analysis of strategies for HLA-compatible platelet selection.

Main Results:

• HLA sensitization poses significant risks, including TRALI and platelet refractoriness.
• Accurate identification of HLA antibody specificities is essential for compatible platelet transfusion.
• Multiple techniques exist for HLA antibody detection and identification.

Conclusions:

• Understanding HLA sensitization mechanisms is key to managing transfusion risks.
• Effective strategies for HLA-compatible platelet provision are vital for patient safety.
• Clinical transfusion medicine requires careful consideration of HLA compatibility.